Log in

Plexus Stock Forecast, Price & News

-1.05 (-1.45 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $71.12
50-Day Range
MA: $75.72
52-Week Range
Now: $71.12
Volume491,955 shs
Average Volume196,526 shs
Market Capitalization$2.08 billion
P/E Ratio18.28
Dividend YieldN/A
Plexus Corp., together with its subsidiaries, provides electronic manufacturing services in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. It offers design and development, supply chain, new product introduction, and manufacturing solutions, as well as aftermarket services. The company provides its solutions to companies in the healthcare and life sciences, industrial and commercial, communications, and aerospace and defense sectors. Plexus Corp. was founded in 1979 and is headquartered in Neenah, Wisconsin.
Read More
Plexus logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.49 out of 5 stars

Industry, Sector and Symbol

Industry Printed circuit boards
Sub-IndustryElectronic Manufacturing Services
Current SymbolNASDAQ:PLXS



Sales & Book Value

Annual Sales$3.16 billion
Cash Flow$5.42 per share
Book Value$29.56 per share


Net Income$108.62 million


Market Cap$2.08 billion
Next Earnings Date10/28/2020 (Estimated)
-1.05 (-1.45 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PLXS News and Ratings via Email

Sign-up to receive the latest news and ratings for PLXS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Plexus (NASDAQ:PLXS) Frequently Asked Questions

How has Plexus' stock price been impacted by COVID-19 (Coronavirus)?

Plexus' stock was trading at $60.68 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PLXS stock has increased by 17.2% and is now trading at $71.12.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Plexus?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Plexus in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Plexus

When is Plexus' next earnings date?

Plexus is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Plexus

How were Plexus' earnings last quarter?

Plexus Corp. (NASDAQ:PLXS) posted its quarterly earnings data on Wednesday, July, 22nd. The technology company reported $1.20 EPS for the quarter, beating the Zacks' consensus estimate of $0.75 by $0.45. The technology company earned $857.39 million during the quarter, compared to the consensus estimate of $801.94 million. Plexus had a net margin of 3.55% and a return on equity of 12.41%.
View Plexus' earnings history

What guidance has Plexus issued on next quarter's earnings?

Plexus updated its fourth quarter earnings guidance on Wednesday, July, 22nd. The company provided earnings per share guidance of $1.05 to $1.20 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.90. The company issued revenue guidance of $850 million to $890 million, compared to the consensus revenue estimate of $820.47 million.

What price target have analysts set for PLXS?

6 brokers have issued 12 month price objectives for Plexus' stock. Their forecasts range from $78.00 to $91.00. On average, they anticipate Plexus' stock price to reach $82.80 in the next twelve months. This suggests a possible upside of 16.4% from the stock's current price.
View analysts' price targets for Plexus

Are investors shorting Plexus?

Plexus saw a drop in short interest during the month of August. As of August 14th, there was short interest totaling 849,300 shares, a drop of 15.1% from the July 30th total of 1,000,000 shares. Based on an average daily trading volume, of 216,000 shares, the days-to-cover ratio is presently 3.9 days. Approximately 3.0% of the shares of the stock are sold short.
View Plexus' Short Interest

Who are some of Plexus' key competitors?

What other stocks do shareholders of Plexus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Plexus investors own include Bristol-Myers Squibb (BMY), Walgreens Boots Alliance (WBA), Pfizer (PFE), Cisco Systems (CSCO), Gilead Sciences (GILD), Intel (INTC), QUALCOMM (QCOM), Twitter (TWTR), Berry Global Group (BERY) and ConocoPhillips (COP).

Who are Plexus' key executives?

Plexus' management team includes the following people:
  • Mr. Todd P. Kelsey, Pres, CEO & Director (Age 54)
  • Mr. Patrick John Jermain, Exec. VP & CFO (Age 53)
  • Mr. Steven J. Frisch, Exec. VP & COO (Age 53)
  • Mr. Angelo M. Ninivaggi, Exec. VP, Chief Admin. Officer, Gen. Counsel & Sec. (Age 52)
  • Mr. Ronald Darroch, Exec. VP of Global Manufacturing Solutions & Regional Pres of AMER (Age 54)

What is Plexus' stock symbol?

Plexus trades on the NASDAQ under the ticker symbol "PLXS."

Who are Plexus' major shareholders?

Plexus' stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (10.45%), Victory Capital Management Inc. (3.66%), Silvercrest Asset Management Group LLC (2.86%), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (2.41%), Fisher Asset Management LLC (1.97%) and Thrivent Financial for Lutherans (1.42%). Company insiders that own Plexus stock include Angelo Michael Ninivaggi Jr, David J Drury, Dean A Foate, Michael V Schrock, Patrick John Jermain, Peter Kelly, Ralf R Boer, Ronnie Darroch, Scott Theune, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey and Yong Jin Lim.
View institutional ownership trends for Plexus

Which major investors are selling Plexus stock?

PLXS stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Vanguard Group Inc., Grantham Mayo Van Otterloo & Co. LLC, Charles Schwab Investment Management Inc., WINTON GROUP Ltd, Nuveen Asset Management LLC, Prudential Financial Inc., and Balyasny Asset Management LLC. Company insiders that have sold Plexus company stock in the last year include Angelo Michael Ninivaggi Jr, David J Drury, Dean A Foate, Michael V Schrock, Patrick John Jermain, Ronnie Darroch, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey, and Yong Jin Lim.
View insider buying and selling activity for Plexus

Which major investors are buying Plexus stock?

PLXS stock was bought by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., New York State Common Retirement Fund, BNP PARIBAS ASSET MANAGEMENT Holding S.A., Assenagon Asset Management S.A., Channing Capital Management LLC, Thrivent Financial for Lutherans, Meritage Portfolio Management, and Intrinsic Edge Capital Management LLC.
View insider buying and selling activity for Plexus

How do I buy shares of Plexus?

Shares of PLXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Plexus' stock price today?

One share of PLXS stock can currently be purchased for approximately $71.12.

How big of a company is Plexus?

Plexus has a market capitalization of $2.08 billion and generates $3.16 billion in revenue each year. The technology company earns $108.62 million in net income (profit) each year or $3.43 on an earnings per share basis. Plexus employs 19,000 workers across the globe.

What is Plexus' official website?

The official website for Plexus is www.plexus.com.

How can I contact Plexus?

Plexus' mailing address is One Plexus Way, Neenah WI, 54957. The technology company can be reached via phone at 920-969-6000 or via email at [email protected]

This page was last updated on 9/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.